A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity.

Source:http://linkedlifedata.com/resource/pubmed/id/21075824

Clin. Cancer Res. 2011 Jan 1 17 1 100-10

Download in:

View as

Triples

General Info

PMID
21075824